Introduction
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB) is one of the major health threats especially in Asia and Africa. In 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease (Anonymous, 2013). Moreover, the vicious interactions between the human immunodeficiency virus (HIV) with TB and emergence of new multi-drug resistant tuberculosis (MDR-TB) have created serious challenges in the control of TB. The current TB control measures include over 20 existing drugs of which isoniazid, ethambutol, pyrazinamide and rifampin are used as front-line drugs (Raman et al., 2008) . But these front line drugs also have several shortcomings like high levels of adverse effects and drug inactivation by the emerging drug-resistant strains (Nunn et al., 2005) . Thus, new drugs are necessary to inhibit the pathogen by targeting its metabolic pathways which are essential for the pathogen to survive.
One of the current effective targets for anti TB drugs is the cell wall biosynthesis. The inhA gene is involved in the production of very-long-chain fatty acids known as mycolic acids, which are one of the major components of the Mycobacterium cell wall formation (Banerjee et al., 1994) . InhA (Rv1484) encodes an NADH-dependent 2-trans-enoyl-ACP reductase which catalyzes the elongation of FAS-II leading to the reduction of 2-trans-enoyl chains (_C12) to obtain the saturated chains Quemard et al., 1995) . The gene inhA has 25% sequence identity to a gene encoding a human protein (pecR) and 31% to a mouse protein (Decr1) making it a "host-safe" target (Hasan et al., 2006) . Drugs like isoniazid and broad spectrum antibacterial Triclosan inhibits the biosynthesis of mycolic acids (Schroeder et al., 2002) . However clinical strains have been isolated which are resistant to isoniazid (Vilchèze et al., 2006) .
The screening of natural products provides greater structural diversity than standard synthetic chemistry and offers significant opportunities for finding novel low molecular weight lead compounds. Moreover, it is a known fact that natural products are the basis of formulations of new synthetic compounds. In traditional medicine, tea (Camellia sinensis), neem (Azadirachta indica) and Ginkgo biloba (Ginkgo biloba) have been used for treatment of various infections. It has been reported that they exhibit anti bacterial, antifungal, anti pesticidal and even anti cancerous properties (Wang and Ng, 2000; Sharma, 2006; Gbotolorun et al., 2008; Schumacher et al., 2011) . Recently tea flavonoids have been accounted as antituberculosis agents (Lin et al., 2002; Lim et al., 2001) . As per our knowledge the above mentioned natural products have not yet been screened against the Mtb InhA target. Considering the importance of InhA in Mtb survival and constantly evolving MDR-TB strains, we have attempted to screen natural compounds as Mtb InhA inhibitors using structure based computer aided drug designing (CADD) method. This study would aid the translational studies and further help in developing novel drugs against Mtb.
Materials and Methods
Preparation of InhA structure The 3D structure of InhA complexed with 2-(2,4-dichlorophenoxy)-5-(pyridine-2-ylmethyl) phenol and Nicotinamide adenine dinucleotide was obtained from the Protein Data Bank [PDB: 3FNE]. InhA consists of four chains namely A with 268 amino acids, B, C and D with 254 amino acids each while the active site residues are located at the chain A. The sequences of the individual chains were aligned using ClustalX. It was found that all the chains had hundred percent similarities and hence only one chain i.e. chain A was selected for the study as it contains the residues of the active site. For the structure-based molecular docking processes the InhA_A structure was prepared by removing all ligands along with the solvents, bound cofactors and by adding polar hydrogen. This was done using the extensible molecular modeling software UCSF Chimera (Pettersen et al., 2004) and energy was minimized using VegaZZ (Pedretti et al., 2004) software. Ten best ligand binding sites were predicted for the molecular docking using the online software Q-SiteFinder (Laurie and Jackson, 2005) .
Preparation of ligands
The IUPAC name and the canonical SMILES of 83 tea polyphenols, 33 neem polyphenols and 38 Gingko biloba compounds were retrieved from PubChem compound (http://www.ncbi.nlm.nih.gov/pccompound). The 2D structures and molecular weights were generated using the software ChemDraw Ultra 8.0 (Cambridge Soft Corporation, MA 02140 U.S.A). 3D structures were subsequently obtained from Online Corina (Sadowski et al., 1994) with the help of SMILES. Drug likeness property was also checked by using online software Molsoft (http://molsoft.com/mprop/). The torsion angles of the ligands were modified by using TORSDOF utility of AutoDock tools and the pdbqt [a special file format generated by AutoDock tools] files of the ligands were generated.
Molecular Docking
AutoDock Vina was used for the Molecular docking (Trott and Olson, 2010) , due to its high speed and accuracy as compared to its predecessor, AutoDock 4 (Morris et al., 2008) . In order to prepare the input pdbqt file for InhA protein and also to set the center and the size of the grid box AutoDock Tools was utilized. The grid box cavity was set as 30 x 30 x 30 and centre was set at x = 31.066, y = 0.295, z = 19.543 for the protein's active site. The scoring function of AutoDock Vina is used to calculate the predicted binding affinity (kcal/mol). This scoring function is divided into two parts: i) a conformation-dependent part which is the sum of intermolecular and intramolecular contributions, including hydrogen bonding, hydrophobic, and steric interactions ii) a conformation -independent part depending on the number of rotatable bonds between heavy atoms in the ligand. The scoring function AutoDock Vina gives a different weight to each of the interactions and number of rotatable bonds (Kakati et al., 2012; Trott and Olson, 2010) . The docking was validated by redocking the InhA active ligands into their binding sites.
Results and Discussion
A structure based approach was taken in this study to find the potential inhibitors against the InhA protein of the Mtb from plant compounds. The coordinates of the grid box in molecular docking play a very important role in ensuring that the ligands bind in the correct conformation to the binding pocket. To validate this study, the cocrystallized ligands were again docked into their binding sites respectively with InhA_A chain of Mtb InhA protein using Autodock tools. The binding conformations were similar to the co-crystallized binding modes of the ligands with binding affinities as given in table 1. The compounds from three different plants viz tea, neem, Gingko biloba were screened with the same coordinates of the grid box. [7] annulen-6-one -7.8 The database of plant compounds were initially subjected to the Lipinski's rule of five for drug like compounds (Lipinski, 2000) . Considering the condition of Lipinski's rule of five for a drug candidate, compounds having molecular weight less than 500D were chosen for performing proteinligand docking. A total of 154 compounds (83 compounds from tea, 33 compounds from neem and 38 compounds from Gingko biloba) were selected for the same. The binding affinity of the selected tea, neem and gingkobiloba compounds to the Mtb InhA protein is given in Table 3 -5 respectively. The best five molecules from each plant, based on their binding affinity to the receptor, were selected for the further study. The hydrogen bonding interaction between the receptor and the ligand was also analyzed using PyMol molecular viewer (http://www.pymol.org). However, among these best binding molecules, tea compounds viz. epicatchin_gallate and phloridzin showed 7 H-bond donors each and epigallocatechin_gallate showed 6 H-bond donors. Thus these molecules were not included further in the study. Similarly, two neem compounds viz. azadirone and kulactone had to be excluded from the study as the lipophilicity (logP) values were found to be higher than 5. The drug likeness property was calculated for the remaining 10 best binding molecules using MolSoft program. The overall drug likeness is predicted by Drug likeness score using MolSoft's fingerprints and Support Vector Machine (SVM) classifier (Lalitha and Sivakamasundari, 2010) . Drug likeness is a balance of diverse molecular properties of the compounds and positive score indicates that the compound has a probability of becoming a successful drug. Among all the remaining compounds, tricetin, a ginkgobiloba compound and gedunin, a neem compound showed a negative drug likeness score. After following the Lipinski's rule of five and checking the drug likeliness property, two tea polyphenols viz. quercetin and apigenin, two neem compound viz. dianabol and nimocinolide and four ginkgobiloba compounds viz. luteolin, kaempferol, quercetin and catechin fall within this barrier (Table 5 ). (Fig. 1A) . The tea polyphenol apigenin had a binding affinity of-8.3kcal/mol and formed three hydrogen bonds: one between O20 and H of Val65 and the other two between O10, Ser94 and Gly14. 
Conclusion
Several potential inhibitory compounds of Mtb are identified in this study. These compounds bound to the NAD active binding site of InhA with higher affinities than the known co-crystallised ligands. Thus these could be a good natural alternative to the first line drugs like isoniazid and ethionamide in controlling MDR-TB. All of these compounds bound to the respective binding sites in the binding pocket. Therefore, these ginkgobiloba, tea and neem compounds can be purified and further used for developing efficient anti-TB drug. In vivo experiments with these compounds could be performed in mice to check its effects and interactions for developing an applied drug for TB. Our study suggests a basis for the design and development of natural novel drugs against TB.
